BACKGROUND: An update of evidence-based guidelines concerning liberation from mechanical ventilation is needed as new evidence has become available. The American College of Chest Physicians (CHEST) and the American Thoracic Society (ATS) have collaborated to provide recommendations to clinicians concerning liberation from the ventilator.
Summary of Recommendations 1. For acutely hospitalized patients ventilated more than 24 h, we suggest that the initial SBT be conducted with inspiratory pressure augmentation (5-8 cm H 2 O) rather than without (T-piece or CPAP) (Conditional Recommendation, Moderate-Quality Evidence)
Remarks: This recommendation relates to how to conduct the initial SBT but does not inform how to ventilate patients between unsuccessful SBTs.
2. For acutely hospitalized patients ventilated for more than 24 h, we suggest protocols attempting to minimize sedation (Conditional Recommendation, Low Quality of Evidence)
Remarks: There is insufficient evidence to recommend any protocol over another.
3. For patients at high risk for extubation failure who have been receiving mechanical ventilation for more than 24 h, and who have passed an SBT, we recommend extubation to preventative NIV (Strong Recommendation, Moderate Quality of Evidence).
Remarks: Patients at high risk for failure of extubation may include those patients with hypercapnia, COPD, congestive heart failure (CHF), or other serious comorbidities. Physicians may choose to avoid extubation to NIV in selected patients for patientspecific factors including but not limited to the inability to receive ventilation through a mask or similar interface. Physicians who choose to use NIV should apply such treatment immediately after extubation to realize the outcome benefits.
Mechanical ventilation is a life-saving intervention, but it is also associated with complications. Therefore, it is desirable to liberate patients from mechanical ventilation as soon as the underlying cause that led to the mechanical ventilation has sufficiently improved, and the patient is able to sustain spontaneous breathing and adequate gas exchange. This clinical practice guideline provides evidence-based recommendations on three specific ventilator liberation techniques. The guidelines were a collaborative effort between the American Thoracic Society (ATS) and the American College of Chest Physicians (CHEST). Development of the guidelines followed systematic reviews of the literature and use of the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework to develop recommendations. The guidelines address the following questions:
Question 1: In acutely hospitalized patients ventilated more than 24 h, should the spontaneous breathing trial (SBT) be conducted with or without inspiratory pressure augmentation?
Question 2: In acutely hospitalized patients ventilated for more than 24 h, do protocols attempting to minimize sedation compared with approaches that do not attempt to minimize sedation impact duration of ventilation, duration of ICU stay, and short-term mortality (60 days)? Question 3: In high-risk patients receiving mechanical ventilation for more than 24 h who have passed an SBT, does extubation to preventive noninvasive ventilation (NIV) compared with no NIV have a favorable effect on duration of ventilation, ventilator-free days, extubation success (liberation > 48 h), duration of ICU stay, shortterm mortality (60 days), or long-term mortality?
This guideline is the companion to another guideline that is being published separately and addresses questions related to physical rehabilitation protocols, ventilator liberation protocols, and the cuff leak test. 1 Neither guideline is intended to impose a standard of care. They provide the basis for rational decisions in the liberation of patients from mechanical ventilation. Clinicians, patients, third-party payers, stakeholders, or the courts should not view the recommendations contained in these guidelines as dictates. Guidelines cannot take into account all the often compelling unique individual clinical circumstances. Therefore, no one charged with evaluating clinicians' actions should attempt to apply the recommendations from these guidelines by rote or in a blanket fashion.
Methods

Expert Panel Composition
CHEST's Professional Standards Committee, Guidelines Oversight Committee (GOC), and the ATS's Document Development and Implementation Committee selected and approved the cochairs of the panel. Prospective panelists were selected by the cochairs based on their expertise relative to the proposed guideline questions. The panelists were reviewed by representatives from both the ATS and CHEST for possible conflicts of interest and credentials. The GOC then reviewed all panelists for final approval. The final panel consisted of the six cochairs and 14 panelists, who were then divided among six topic groups as content experts for their particular area of expertise.
Conflicts of Interest
All panel nominees were reviewed and vetted by a joint conflict of interest (COI) review committee composed of members from the ATS and CHEST. After review, nominees who were found to have no substantial COI were approved, whereas nominees with potential intellectual and financial COIs that were considered to be manageable were "approved with management." Panelists who were approved with management were prohibited from participating in discussions or voting on recommendations in which they had substantial COI. We created a grid associating panelists' COI with relevant population, intervention, comparator, outcome (PICO) questions for use during voting. The COI grid can be found in e- Table 1 .
The final panel consisted of the six cochairs (T. D. G., J. P. K., P. E. M., D. R. O., G. A. S., and J. D. T.), seven pulmonary/critical care physicians, four critical care physicians, one critical care nurse, one physical therapist, and one critical care pharmacist. The panel worked with two methodologists (W. A. and S. P.), one of whom is also a critical care physician.
Formulation of Key Questions and Outcome Prioritization
The six cochairs drafted a total of six key clinical questions in a PICO format ( Table 1) . The cochairs were asked to rate the outcomes to be used for all six questions numerically on a scale of 1 to 9, according to the GRADE Working Group's three categories of outcomes for decision-making (1-3 ¼ not important; 4-6 ¼ important; 7-9 ¼ critical). We used the cochairs' average score for each outcome to determine the outcome category, and we assessed only the outcomes rated as "critical" or "important."
Systematic Literature Searches
All panelists reviewed the PICO questions and, with the help of the methodologist, finalized the search terms, inclusion and exclusion criteria, and databases that would be searched.
The methodologist performed a systematic search of the literature for relevant systematic reviews and individual studies in December 2014 using the following databases: MEDLINE via PubMed, the Cochrane Library, and CINAHL. Searches were conducted using a combination of the National Library of Medicine's Medical Subject Headings and other key words specific to each topic. Reference lists from relevant retrievals were also searched, and additional papers were manually added to the search results. To account for all the literature pertaining to each topic, searches were not limited by language, study design, or publication date. Additional details on literature searches and the selection of studies can be found in e- Figures 1-3 .
Study Selection and Data Extraction
Studies retrieved from the completed literature searches were then reviewed for relevance through two rounds of screening. Two reviewers excluded studies that did not meet the inclusion criteria based on title or abstract. We retrieved studies that met the inclusion criteria for full-text review to determine their final inclusion. In both rounds of screening, studies were reviewed independently by two reviewers. Disagreements were resolved through discussion or by a third reviewer if required.
We extracted relevant data from each eligible study into structured data tables. One panelist performed the data extraction and another panelist independently reviewed the extracted data. Discrepancies were resolved by discussion. A discrepancy resolution plan using a third reviewer was in place but never invoked.
Risk of Bias Assessment
The methodologist assessed the risk of bias in all included studies. We used the Cochrane Risk of Bias tool to assess risk of bias for randomized controlled trials. 2 We used the Documentation and Appraisal Review Tool to assess the quality of systematic reviews when applicable. 
Meta-Analyses
When individual studies were available or a meta-analysis needed to be updated, we used the Cochrane Collaboration Review Manager, version 5.2 4 to pool the results across individual studies. We used a random-effects model and the method of DerSimonian and Laird to pool the individual estimates. 5 Relative risk (RR) was used to report the results for dichotomous outcomes and mean difference for continuous outcomes with accompanying 95% CIs. Statistical heterogeneity of the pooled results was assessed using the Higgins' I 2 test and the c 2 test. A Higgins' I 2 value of $ 50% or a c 2 P < .05 was considered to represent significant heterogeneity. 
Assessing the Certainty of Evidence
We assessed the overall certainty of the evidence for each outcome of interest using the GRADE approach. 6 Evidence profiles were created using the Guideline Development Tool, which categorized the overall quality of the body of evidence into one of four levels: high, moderate, low, or very low. Each level represents the confidence in the estimated effects for a specific question (Table 2) . Panel members in each group reviewed the evidence profiles and provided input and feedback.
Recommendations
The panel developed recommendations for each of the PICO questions based on the GRADE evidence profiles. We used the Evidence to Decision (EtD) framework to guide the discussions that ultimately led to the development of a recommendation (e- Tables 3-5) . Panel members made decisions regarding the balance between benefits and harm, impact of patients' values and preferences, cost, health equity, feasibility, and acceptability of the intervention. Pertinent points were recorded during the discussion process. The advantage of using the EtD framework was to facilitate the discussion and to ensure that all important categories were discussed before formulating the recommendation.
Recommendations were graded using the GRADE approach. 7 The recommendations were either "strong"
or "conditional" (weak) according to this approach. Strong recommendations use the wording "we recommend," and conditional recommendations use the wording "we suggest." The implications of the strength of recommendations are summarized in Table 3 .
Consensus Development
The guideline panel met through online webinars multiple times to work through the EtD and develop recommendations for each PICO question. Because all panel members were not able to attend every webinar, all drafted recommendations were presented again to the full panel in an online anonymous voting survey to reach consensus and gather feedback from those unable to participate. Panelists were requested to indicate their level of agreement on each recommendation based on a five-point Likert scale derived from the GRADE grid. 8, 9 Panelists were also invited to provide feedback on each recommendation with suggestions for rewording.
Panelists with COIs (per the terms of management) were not permitted to vote on the related recommendation.
No panelists had conflicts that required exclusion from voting. Approval of each recommendation required (by CHEST policy) a 75% voting participation rate and an 80% consensus. Any recommendation that did not meet these criteria was revised by the panel based on the feedback, and a new survey that incorporated those revisions was completed.
Peer Review Process
Reviewers from the GOC, the CHEST Board of Regents, and the CHEST journal reviewed the content and methods, including consistency, accuracy, and completeness. The manuscript was revised after consideration by the panel of the feedback received from the peer reviewers. Clinicians tend to underestimate the capacity of patients to breathe successfully when disconnected from the ventilator, as shown by two large weaning trials. 10, 11 Moreover, weaning predictors such as maximal inspiratory pressure, static respiratory system compliance, and rapid/shallow breathing index lack sufficient positive and negative predictive value to make them routinely useful for judging patients' ability to wean. Once patients meet several readiness criteria, a preferred approach is to conduct a SBT involving little or no ventilator support. If the SBT provokes signs of respiratory failure, ventilation is resumed, but if it does not, the clinician may move toward extubation.
The SBT can be conducted using no inspiratory pressure augmentation (T-piece or CPAP) or with modest inspiratory pressure augmentation (pressure support, generally limited to 5-8 cm H 2 O, or automatic tube compensation). On the one hand, it could be argued that the patient demonstrating an ability to breathe while receiving no inspiratory pressure augmentation has convincingly shown weaning readiness (ie, this result may be very specific but may not be sensitive). On the other hand, some patients failing an SBT without pressure augmentation might pass with pressure support, and some of these patients may be safely extubated (ie, this result may be more sensitive but less specific). There is no consensus about how to conduct the SBT, leading to differing approaches across ICUs.
Summary of the Evidence
We conducted a systematic review that identified four relevant trials, and these formed the evidence base that served to guide the panel's recommendations. [12] [13] [14] [15] All were prospective and randomized, and three were singlecenter trials. Three of the trials enrolled patients from mixed medical/surgical ICUs, whereas one trial enrolled patients from a medical ICU. 13 In all trials, patients had to be judged clinically stable and ready for weaning to be considered for study participation. For the SBT, subjects were allocated to T-piece breathing (no pressure augmentation) or to a modest level of pressure support (pressure augmentation) for a period of 30 min to 2 h. The amount of pressure support provided was 5, 7, or 8 cm H 2 O or through automatic tube compensation (which provides inspiratory pressure support to overcome work of breathing imposed by the artificial airway).
The SBT was terminated if the patient exhibited signs of poor tolerance; otherwise, the SBT was considered successful ("successful SBT"). When the SBT was successful, the patient was extubated at the end of the period and provided supplemental oxygen. "Extubation success" was defined as not requiring reintubation or NIV in the following 48 h. Table 2 ).
There are several limitations to the studies used for analysis. The clinicians in the studies were unblinded to SBT technique. In addition, the total number of subjects in the trials was small, and three of the four trials were performed in a single center. The mixed ICU populations from which study subjects were drawn limit our confidence when applying these results to individual patients. This is especially the case in subsets that accounted for only a small minority of all patients studied (eg, those with respiratory failure due to neuromuscular disease). Finally, study patients were those undergoing their first SBT, thus limiting generalizations to those who have failed one or more previous SBTs.
The evidence used to guide this recommendation was of moderate confidence for SBT and extubation success but of low certainty for ICU mortality (Table 4) . We considered, but did not include for meta-analysis, one additional trial that conducted the SBT initially using a T-piece and, if that failed, extended the duration using pressure support of 7 cm H 2 O for 30 minutes. 16 If the SBT with pressure augmentation was successful, patients were extubated. Of all enrolled subjects (N ¼ 118), 31 failed the SBT without pressure augmentation, but 21 of these patients were successful following pressure augmentation and were extubated. The rates of extubation success were similar in those who passed the SBT without pressure augmentation and those who failed initially but passed when pressure augmentation was added, further supporting our recommendation.
journal.publications.chestnet.org One study with unclear randomization methods, 1 study with unclear allocation concealment methods, and 2 studies with unclear reports on outcome assessment. b Low number of events; 95% CI crosses line of no effect. The panel judged that the desirable consequences of conducting the SBT with pressure augmentation outweighed any potential undesirable consequences. This judgment was based on the success of the SBT conducted with pressure augmentation as well as the high rate of extubation success associated with the intervention.
CHEST/ATS Recommendation 1. For acutely hospitalized patients ventilated more than 24 h, we suggest that the initial SBT be conducted with inspiratory pressure augmentation (5-8 cm H 2 O) rather than without (T-piece or CPAP) (Conditional Recommendation, Moderate Quality Evidence).
Values and Preferences
This recommendation places a high value on reducing the duration of mechanical ventilation and maximizing the probability of extubation success.
Question 2: In acutely hospitalized patients ventilated for more than 24 h, do protocols attempting to minimize sedation compared with approaches that do not attempt to minimize sedation impact duration of ventilation, duration of ICU stay, and short-term mortality (60 days)?
Background
Mechanically ventilated patients often receive sedative and analgesic drugs for a variety of reasons. These drugs have the potential to alter mental status and suppress respiratory drive. Accordingly, it is conceivable that these pharmacologic effects may impede liberation from mechanical ventilation. Strategies to minimize the effects of these drugs (eg, bedside nursing sedation algorithms, daily sedative interruption) have been used for several decades. We sought to review the published evidence evaluating the utility of sedation minimization strategies on duration of ventilation, duration of ICU stay, and short-term mortality (60 days).
Summary of the Evidence
We performed a systematic review that included six relevant trials. [17] [18] [19] [20] [21] [22] These six trials formed the evidence base that was used to inform the guideline panel's judgment. All were unblinded randomized trials that compared cohorts of patients managed with protocols that minimized sedation to cohorts of patients that were not managed with such protocols. Three studies used nursing sedation algorithms, and three used protocols for daily sedative interruption. The studies included patients from both medical and surgical ICUs. For the outcomes of duration of ventilation and duration of ICU stay, all six trials had relevant data. For the outcome of short-term mortality, only three of the studies had relevant data. 17, 19, 20 The outcome of duration of mechanical ventilation was assessed by the group to be of critical importance. Six trials were pooled through meta-analysis for the outcome of duration of mechanical ventilation (695 patients received protocolized sedation and 699 patients received no protocolized sedation [e- Table 2] ). The six studies were judged to have serious risk of bias. The majority of studies did not blind patients, personnel, or outcome assessors. Additionally, protocol adherence was not measured or reported in the majority of studies. They were also noted to have serious levels of inconsistency and imprecision (ie, wide CIs around the absolute effect). Accordingly, the evidence was noted to be of very low quality.
Six trials were pooled through meta-analysis for the outcome of ICU length of stay (695 patients received protocolized sedation and 699 patients received no protocolized sedation). This outcome was noted by the group to be of critical importance. The six studies were noted to have serious risk of bias. They were also noted to have serious levels of inconsistency and imprecision. Accordingly, the evidence was noted to be of very low quality.
Six trials were pooled through meta-analysis for the outcome of short-term mortality (203 of 695 cases of mortality had protocolized sedation and 217 of 699 cases of mortality had no protocolized sedation). This outcome was noted by the group to be of critical importance. The six studies were noted to have serious risk of bias. In contrast to the previous two PICO outcome questions, the levels of inconsistency and imprecision were not noted to be serious. Accordingly, the evidence was noted to be of moderate quality.
The summary of the pooled evidence showed no significant difference in the duration of mechanical ventilation in the protocolized sedation group (mean difference 1 day shorter; 95% CI, from 2.14 to 0.14) ( Table 5 ). The summary of the pooled evidence showed a shorter ICU length of stay in the protocolized sedation group (mean difference, 1.78 days shorter; 95% CI, -3.41 to -0.14). The summary of the pooled evidence showed no significant difference in short-term mortality in the protocolized sedation group (RR, 0.93; 95% CI, 0.77-1.11; P ¼ .42).
An important limitation of the evidence subjected to meta-analysis was the wide variation in management of the control groups across the six studies. Those studies demonstrating no benefit of protocolized sedation strategies tended to have lighter levels of sedation in the control groups compared with those that did demonstrate a benefit.
Two studies that may inform practitioners concerning sedation strategies were not included in the analysis. One study that randomized 430 patients receiving mechanical ventilation to either a sedation protocol or to a sedation protocol plus daily sedation interruption demonstrated no difference in the duration of mechanical ventilation or in ICU length of stay. 23 In a different approach, Strom et al 24 enrolled 140 patients receiving mechanical ventilation in a study that assigned patients to receive no sedation as the study intervention, compared with a sedation protocol with daily sedation interruption. Of the patients who were alive and receiving mechanical ventilation after 48 h, patients in the "no sedation" group had more ventilator-free days, and a shorter ICU stay, than did those receiving daily sedation interruption. These studies were not included in the analysis because their intervention and comparator treatments did not match those stipulated by the PICO question.
Despite the limitations of the evidence, the panel judged the desirable effects of sedation protocols aimed at minimizing sedation (shorter duration of ICU stay and possible trend of reduced duration of ventilation) to outweigh the undesirable effects associated with not minimizing sedation in ventilated patients.
CHEST/ATS Recommendation 2. For acutely hospitalized patients ventilated for more than 24 h, we suggest protocols attempting to minimize sedation (Conditional Recommendation, Low Quality of Evidence).
Values and Preferences
This recommendation places a high value on reducing mechanical ventilation duration and ICU length of stay and views the burden of protocolized sedation as very low.
Question 3: In high-risk patients receiving mechanical ventilation for more than 24 h who have passed an SBT, does extubation to preventive NIV compared with no NIV have a favorable effect on duration of ventilation, ventilator-free days, extubation success (liberation > 48 h), duration of ICU stay, short-term mortality (60 days), or long-term mortality?
Background: Patients intubated for acute respiratory failure are at increased risk for complications including infection and multisystem organ failure. 25 The risk for complications and mortality rises with increasing duration of mechanical ventilation, as do the associated health care costs. 26 Delaying endotracheal tube removal in patients who otherwise appear ready for extubation adversely affects outcome by increasing the risk for pneumonia and the length of ICU and hospital stays when compared with patients extubated in a timely manner. 27 Conversely, studies have found that patients requiring reintubation (extubation failure) after satisfactorily tolerating an SBT have increased risk for complications, prolonged hospital stay, and significantly increased mortality.
28
NIV improves outcomes in patients with acute respiratory failure. Application of NIV to patients with respiratory failure due to acute exacerbations of COPD reduces the need for intubation, the frequency of complications, the hospital length of stay, and the mortality rate compared with standard therapy. 29 Patients with acute cardiogenic pulmonary edema and respiratory failure have a more rapid improvement in respiratory distress, hypercapnia, metabolic acidosis, and reduction in intubation rate when NIV is used compared with oxygen therapy alone. 30 The use of NIV in immunocompromised hosts with diffuse pulmonary infiltrates reduces the intubation rate as well as ICU and hospital mortality. 31 Although there has been considerable support for the use of NIV in selected groups of patients presenting with respiratory failure, the results have been less well defined for the application of NIV in patients following extubation. In one randomized trial in 221 patients who experienced respiratory failure a mean of 9 h after extubation, NIV was not effective in reducing the need for reintubation and was associated with a higher ICU mortality rate in comparison with standard medical therapy (including supplemental oxygen and bronchodilators) in at-risk patients who had been extubated following a successful SBT but subsequently experienced respiratory failure. 32 In contrast, other trials
show that NIV applied immediately after extubation may reduce reintubation rates in critically ill patients, with meta-analyses of these studies indicating that duration of mechanical ventilation, ventilator-associated pneumonia, ICU length of stay, hospital length of stay, and mortality may also be improved. 33, 34 We examined available data on the use of NIV immediately after extubation for ventilated patients who had passed an SBT and were at high risk of extubation failure to determine the effect of this treatment on the need for reintubation, ICU length of stay, and short-and longterm mortality.
Summary of the Evidence
Five randomized controlled trials met criteria for our assessment of the data. Nava et al 35 examined outcomes in 120 patients randomized to NIV or an oxygen mask. They found that patients treated with NIV had reduced ICU mortality (6.6% vs 16.6%; P < .035) and reintubation rates (15% vs 25%; P ¼ .04) when compared with control subjects.
In assessing the aggregate data, all five studies addressed extubation success. NIV was favored over standard care in high-risk patients following extubation (RR, 1.14; 95% CI, 1.05-1.23) ( Table 6 ). Four studies [35] [36] [37] 39 examined the outcomes of ICU length of stay and shortterm mortality, with the finding that NIV was significantly better than conventional therapy for each outcome (ICU length of stay: mean difference, - These studies became available after the literature search was conducted but may inform clinicians about postextubation strategies similar to preventive NIV.
The panel judged the desirable consequences of extubation to preventative NIV to clearly outweigh the undesirable consequences. The desirable consequences considered by the panel included improved extubation success as well as a 2-day reduction of ICU length of stay. The panel noted that potential undesirable consequences of NIV include nasal bridge damage, conjunctivitis, and nasal ulceration. However, the desirable consequences outweigh these potential harms.
CHEST/ATS Recommendation 3. For patients at high risk for extubation failure who have been receiving mechanical ventilation for more than 24 h, and who have passed an SBT, we recommend extubation to preventative NIV (Strong Recommendation, Moderate Grade of Evidence).
Remarks: Patients at high risk for failure of extubation may include those patients with hypercapnia, COPD, CHF, or other serious comorbidities. Physicians may choose to avoid extubation to NIV in selected patients for patient-specific factors including but not limited to the inability to receive ventilation through a mask or similar interface. Physicians who choose to use NIV should apply such treatment immediately after extubation to realize the outcome benefits.
Values and Preferences
This recommendation places a high value on early extubation, which will lead to substantial benefits including a reduction in ventilator-related and ICUrelated complications and to reductions in health-care costs accruing from a reduction in ICU stay.
Summary
These clinical practice guidelines include a strong recommendation that patients who are at high risk for extubation failure and who have passed an SBT be extubated to preventive NIV. Moderate-quality evidence exists that clinically important outcomes are improved by this strategy. Conditional recommendations are to use inspiratory pressure augmentation during the initial SBT and to use protocols to minimize sedation in patients ventilated for more than 24 h. The latter two recommendations are limited by the quality of the available evidence. As further research becomes available, these recommendations will be readdressed and updated.
